Survival of Interleukin-17 and Interleukin-23 Inhibitors in Patients Previously Treated with a Tumor Necrosis Factor Inhibitor: Analysis of the Spanish Biobadaderm Registry Raquel Rivera-Díaz; Alicia Quesada; Antonio Sahuquillo-Torralba; Esteban Daudén; José Manuel Carrascosa; Isabel Belinchón; Franciso José Gomez Garcia; Enrique Herrera Acosta; Diana P. Ruiz Genao; Ofelia Baniandrés Rodriguez; Marta Ferrán Farres; Pablo de la Cueva Dobao; Lourdes Rodriguez Fernández-Freire; Almudena Mateu Puchades; Josep Riera-Monroig; Jose Carlos Ruiz Carrascosa; Mariano Ara Martín; MªTeresa Abalde Pintos; Monica Roncero Riesco; Jose Luis Lopez-Estebaranz; Carmen García-Donoso; Ignacio García-Doval; Miguel Angel Descalzo;

Relation between gut microbiome and inflammatory interleukins in psoriasis patients compared to healthy controls: an observational study L. Schneller-Pavelescu; C. Mora-Martínez; MJ. Sánchez-Pujol; Y. Sanz; E. Caparrós-Cayuela; R. Francés-Guarinos; JM. Ramos-Rincón; I. Belinchón-Romero;

Tildrakizumab 200 mg. Is double dosing really a window of opportunity? Carlos Llamas-Segura; Marta Cebolla-Verdugo; Ricardo Ruiz-Villaverde;